Jgpxwuhptcfxxk1kaciy abx

ABX-CRO advanced pharmaceutical services GmbH

Dresden, DE

ABX-CRO is a globally operating clinical research organization with a strong focus on pre-clinical and clinical molecular imaging and molecular radiotherapy.

Based on over 15 years of experience in diagnostic and therapeutic oncology, neurology and other disease areas, ABX-CRO provides you with unique opportunities to test your drug candidates in complex pre-clinical disease models, assessed quantitatively using molecular and functional imaging (PET, SPECT, CT, MRI). We translate pre-clinical results into First in Man studies and support you with design and execution of efficient late stage clinical trials, minimizing your costs and time to marketing authorization. ABX-CRO makes translational medicine a visible reality.

To facilitate your molecular radiotherapy development or daily clinical practice, we are presenting QDOSE, our integrated radiation dosimetry package. QDOSE is a comprehensive and versatile... Show more »

ABX-CRO is a globally operating clinical research organization with a strong focus on pre-clinical and clinical molecular imaging and molecular radiotherapy.

Based on over 15 years of experience in diagnostic and therapeutic oncology, neurology and other disease areas, ABX-CRO provides you with unique opportunities to test your drug candidates in complex pre-clinical disease models, assessed quantitatively using molecular and functional imaging (PET, SPECT, CT, MRI). We translate pre-clinical results into First in Man studies and support you with design and execution of efficient late stage clinical trials, minimizing your costs and time to marketing authorization. ABX-CRO makes translational medicine a visible reality.

To facilitate your molecular radiotherapy development or daily clinical practice, we are presenting QDOSE, our integrated radiation dosimetry package. QDOSE is a comprehensive and versatile stand-alone, user-friendly, vendor-neutral software solution, integrating all steps required for a full dosimetry from image import to a report with maximum flexibility. It includes multiple workflows in one package: planar, hybrid, volumetric and SIRT dosimetry and addresses safety as well as efficacy dosimetry. QDOSE has been validated extensively.

Recent Publications

  • Koch, Walter; Unterrainer, Marcus; Xiong, Guoming; Bartenstein, Peter; Diemling, Markus; Varrone, Andrea et al. (2014): Extrastriatal binding of (1)(2)(3)IFP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. In: European Journal of Nuclear Medicine and Molecular Imaging 41 (10), S. 1938–1946. DOI: 10.1007/s00259-014-2785-8.
  • Albertoni, Claudio; Leoni, Barbara; Rosi, Antonio; D'Alessio, Valeria; Carollo, Valeria; Spagnoli, Luigi Giusto et al. (2015): Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm. In: Cancer Biotherapy & Radiopharmaceuticals 30 (7), S. 291–298. DOI: 10.1089/cbr.2015.1837.
  • Albert, Nathalie L.; Unterrainer, Marcus; Diemling, Markus; Xiong, Guoming; Bartenstein, Peter; Koch, Walter et al. (2016): Implementation of the European multicentre database of healthy controls for (123)IFP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. In: European Journal of Nuclear Medicine and Molecular Imaging 43 (7), S. 1315–1322. DOI: 10.1007/s00259-015-3304-2.
  • Buchert, Ralph; Kluge, Andreas; Tossici-Bolt, Livia; Dickson, John; Bronzel, Marcus; Lange, Catharina et al. (2016): Reduction in camera-specific variability in (123)IFP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. In: European Journal of Nuclear Medicine and Molecular Imaging 43 (7), S. 1323–1336. DOI: 10.1007/s00259-016-3309-5.
  • Baum, Richard P.; Kluge, Andreas W.; Kulkarni, Harshad; Schorr-Neufing, Ulrike; Niepsch, Karin; Bitterlich, Norman; van Echteld, Cees J. A. (2016): (177)Lu-DOTA(0)-D-Phe(1)-Tyr(3)-Octreotide ((177)Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study. In: Theranostics 6 (4), S. 501–510. DOI: 10.7150/thno.13702.
  • Kratochwil, Clemens; Giesel, Frederik L.; Stefanova, Melsa; Benesova, Martina; Bronzel, Marcus; Afshar-Oromieh, Ali et al. (2016): PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617. In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 57 (8), S. 1170–1176. DOI: 10.2967/jnumed.115.171397.
« Show less

ABX-CRO advanced pharmaceutical services GmbH has not listed any services.

Ask A Question Find what you're looking for? If not, you can ask this lab a question:
Medical Device Clinical Trials
Price on request
Request a quote for more information about this service.
Clinical Positron Emission Tomography
Price on request

Phase 0 studies, also called micro-dosing studies, are a new regulatory category, guided by the EMEA (CPMP/SWP/2599/02, 2003) and FDA (Exploratory IND draft, 2005) allowing to perform human studies with a considerably reduced tox package, compared to a conventional first in human study, provided that not more than 100 µg substance... Show more »

Phase 0 studies, also called micro-dosing studies, are a new regulatory category, guided by the EMEA (CPMP/SWP/2599/02, 2003) and FDA (Exploratory IND draft, 2005) allowing to perform human studies with a considerably reduced tox package, compared to a conventional first in human study, provided that not more than 100 µg substance are administered.

For CNS drug candidates, microdosing is of special interest to investigate BBB penetration, receptor binding, or dose-to-target-organ relationships. Also, first evidence on metabolism can be obtained. Microdosing represents a considerable cost and time advantage and helps to minimise attrition rates in CNS compound development.

ABX-CRO offers different PET study types

Pharmacokinetic PET studies

PET studies using radioanalogues of NCEs labelled with 11carbon allow to quantitatively assess pharmacokinetics and metabolism. In combination with behavioural, clinical or paraclinical data, pharmacokinetic PET studies allow the establishment of dose-efficacy relationships and dose finding.

Pharmacodynamic PET studies

PET studies using cold NCEs in combination with established radiotracers allow to assess pharmacodynamic properties. Using metabolic tracers such as e.g. [18F]FDG, drug effects on metabolism can be studied. Using [11C]-labelled standard ligands to a target molecule, receptor binding properties of the NCE can be assessed in vivo by displacement studies.

PET tracer development studies

For PET radiopharmaceuticals to be developed as diagnostic products in their own right, ABX-CRO performs integrated development programmes from preclinical through to registration.

Services include:

  • Strategy consultancy
  • Custom labelling (11C, 18F, 68Ga)
  • GMP-radiosynthesis
  • Radiopharmacology & dosimetry
  • Human dosimetry
  • Advanced data analysis
  • Kinetic modelling
  • Receptor occupancy
  • Full service projects
« Show less
Pharmaco-Imaging
Price on request

As a dedicated Molecular and Functional Imaging Core Lab, we provide you with comprehensive turn-key solutions covering all aspects of pre-clincal and clinical Imaging:

  • Design of Imaging Studies or Sub-studies
  • Site set-up, including
    • Camera QA and certification for study purposes
    • Quantitative cross-calibration... Show more »

As a dedicated Molecular and Functional Imaging Core Lab, we provide you with comprehensive turn-key solutions covering all aspects of pre-clincal and clinical Imaging:

  • Design of Imaging Studies or Sub-studies
  • Site set-up, including
    • Camera QA and certification for study purposes
    • Quantitative cross-calibration of PET, SPECT & MRI scanners
  • Multicentre PET, SPECT & MRI studies, including
    • Quantitative normalisation of multi-institutional data
    • Handling of data in proprietary formats
  • Set-up of world-class image analysis panels for
    • Visual,
    • Semiquantitative (SUV) or
    • Quantitative analysis, e.g.
    • Kinetic modelling,
    • Receptor occupancy studies
« Show less
Single Photon Emission Computed Tomography Image Analysis
Price on request

Absolute quantification of activity concentrations (Bq/ml) can establish direct comparability of parametric images between systems, points in time, or different subjects.

Using camera-specific calibration factors, along with standardized attenuation and scatter correction, the QSPECT suiteTM, enables absolute quantification of... Show more »

Absolute quantification of activity concentrations (Bq/ml) can establish direct comparability of parametric images between systems, points in time, or different subjects.

Using camera-specific calibration factors, along with standardized attenuation and scatter correction, the QSPECT suiteTM, enables absolute quantification of SPECT data obtained on any conventional SPECT or SPECT/CT system. The quantitative comparison of image data between sites (multi-centre setting), intra-individually (follow-up), or against reference data is facilitated.

QSPECT was developed by Prof. Hidehiro Iida at the NCVC, Osaka, Japan.

*The QSPECT suite*TM

The QSPECT suiteTM consists of a core module for quantitative reconstruction, specialized modules for summary report, and a regions-of-interest analysis tool. One or two sets of single- or dynamic-frame images can be reconstructed, in which the two images may be co-registered, enabling two independent scans being combined in a single analysis.

The quantitative accuracy and inter-equipment reproducibility have been demonstrated in previous studies. Several phantoms including a 3-dimensional brain phantom with a realistic head contour and precise grey matter and skull-equivalent structures are available. Experience in more than 186 clinical institutions on more than 60000 clinical scans is a strong support for real quantitative studies using existing SPECT cameras installed at clinical environment.

« Show less
Small Animal SPECT Scan
Small Animal Single Photon Emission Computed Tomography Scan
Price on request
  • Multicentre PET, SPECT & MRI studies, including
    • Quantitative normalisation of multi-institutional data
    • Handling of data in proprietary formats
  • Multicentre PET, SPECT & MRI studies, including
    • Quantitative normalisation of multi-institutional data
    • Handling of data in proprietary formats
« Show less
Data Management
Price on request

Our data management team brings their extensive industry experience to any project. Combining their expertise with our robust CDMS and IT infrastructure, it allows our clients the peace of mind that their data will be captured and validated in strict accordance with industry standards and FDA regulations.
ABX-CRO utilises a... Show more »

Our data management team brings their extensive industry experience to any project. Combining their expertise with our robust CDMS and IT infrastructure, it allows our clients the peace of mind that their data will be captured and validated in strict accordance with industry standards and FDA regulations.
ABX-CRO utilises a validated, 21 CFR part 11 compliant off-the-shelf EDC/ CDMS solution that is capable of handling small single site Phase 1 trials, as well as multinational Phase 3 and 4 trials with ease.

Our services include:

  • eCRF, paper CRF or Hybrid solution
  • CRF Design / guidelines
  • Double Data entry (paper)
  • Medical Coding
  • Electronic loading of external data (i.e. laboratory or central ECG)
  • CDISC compliant databases
« Show less
Safety Pharmacology
Price on request

Human radiation safety and efficacy dosimetry in diagnostic and therapeutic imaging using PET and SPECT radionuclides

Human radiation safety and efficacy dosimetry in diagnostic and therapeutic imaging using PET and SPECT radionuclides

« Show less
Toxicology
Price on request

Toxicology studies from mice to NHP

Toxicology studies from mice to NHP

« Show less
Mouse
Non-human primates
Biostatistical Analysis
Price on request

ABX-CRO´s biostatistics department is headed by Dr. Norman Bitterlich, a pragmatic mathematician, understanding the needs of clinical research and familiar with standard and advanced biostatistical methods (e.g. fuzzy methods).

Sound case number estimations, based on even scarce early phase or literature data, help to minimize... Show more »

ABX-CRO´s biostatistics department is headed by Dr. Norman Bitterlich, a pragmatic mathematician, understanding the needs of clinical research and familiar with standard and advanced biostatistical methods (e.g. fuzzy methods).

Sound case number estimations, based on even scarce early phase or literature data, help to minimize our sponsors risk, always having in mind the best trade-off between cost reduction, and trial success.

CFR part 11 compliant high-security hard & software, state-of-the–art customizable EDC solutions, along with specific understanding for the peculiarities of image data, make our biostatistics department an attractive partner for isolated biostatistics projects, or full service projects alike.

By the way - Dr. Norman Bitterlich is a direct decendent of Germany´s famous calculus master Adam Ries (1492 – 1559), who introduced the Arabic numbering system to central Europe.

« Show less
Phase III Clinical Trials
Price on request

International multicentre phase II and III trials are challenging for the sponsor, due to differences in language, health care systems, regulatory environments, medical practice, and cultural background.

From our experience with smaller phase II and larger phase III trials, we have come to learn the importance of respecting the... Show more »

International multicentre phase II and III trials are challenging for the sponsor, due to differences in language, health care systems, regulatory environments, medical practice, and cultural background.

From our experience with smaller phase II and larger phase III trials, we have come to learn the importance of respecting the local specificities of each country, while placing extreme importance on assuring high standards and comparable data quality for each participating site.
For the successful placement of multinational trials, ABX-CRO provides you with all relevant information, not only on epidemiology and suitable investigators, but also on the regulatory environment, health care system, local therapeutic guidelines, or potential competitive projects.

With our own or collaborative offices in Australia, Brazil, France, Italy, Japan, South Africa, Switzerland, and the US, and a network of home based pharmaceutical research experts, we provide global clinical coverage, at highest quality, affordable not only for big pharma.

« Show less
Phase II Clinical Trials
Price on request

International multicentre phase II and III trials are challenging for the sponsor, due to differences in language, health care systems, regulatory environments, medical practice, and cultural background.

From our experience with smaller phase II and larger phase III trials, we have come to learn the importance of respecting the... Show more »

International multicentre phase II and III trials are challenging for the sponsor, due to differences in language, health care systems, regulatory environments, medical practice, and cultural background.

From our experience with smaller phase II and larger phase III trials, we have come to learn the importance of respecting the local specificities of each country, while placing extreme importance on assuring high standards and comparable data quality for each participating site.
For the successful placement of multinational trials, ABX-CRO provides you with all relevant information, not only on epidemiology and suitable investigators, but also on the regulatory environment, health care system, local therapeutic guidelines, or potential competitive projects.

With our own or collaborative offices in Australia, Brazil, France, Italy, Japan, South Africa, Switzerland, and the US, and a network of home based pharmaceutical research experts, we provide global clinical coverage, at highest quality, affordable not only for big pharma.

« Show less
Clinical Magnetic Resonance Imaging (MRI)
Clinical Magnetic Resonance Imaging
Price on request

Imaging studies with PET or MRI are of particular interest for drug developments in oncology and the neurosciences. Whether you require small animal imaging in tumor-bearing rodents, or CNS imaging in small or large non-human primates (marmosets, cynomoglus apes), ABX-CRO with its top class service partners provides you with a... Show more »

Imaging studies with PET or MRI are of particular interest for drug developments in oncology and the neurosciences. Whether you require small animal imaging in tumor-bearing rodents, or CNS imaging in small or large non-human primates (marmosets, cynomoglus apes), ABX-CRO with its top class service partners provides you with a turn-key solution, ranging from radiopharmaceutical services (e.g custom labelling of drug candidates), through advanced experimental or surgical interventions, performed by specially trained veterinarians, up to quantitative data analysis, using standard or special solutions, optimised around the study purposes. If human metabolism is to be modelled, mini-pig imaging may be an attractive alternative to primate imaging.

According to sponsor and project requirements, we offer PET projects in collaboration with leading institutions in Europe, North America and Japan.

« Show less
Small Animal PET Scan
Small Animal Positron Emission Tomography Scan
Price on request

Phase 0 studies, also called micro-dosing studies, are a new regulatory category, guided by the EMEA (CPMP/SWP/2599/02, 2003) and FDA (Exploratory IND draft, 2005) allowing to perform human studies with a considerably reduced tox package, compared to a conventional first in human study, provided that not more than 100 µg substance... Show more »

Phase 0 studies, also called micro-dosing studies, are a new regulatory category, guided by the EMEA (CPMP/SWP/2599/02, 2003) and FDA (Exploratory IND draft, 2005) allowing to perform human studies with a considerably reduced tox package, compared to a conventional first in human study, provided that not more than 100 µg substance are administered.

For CNS drug candidates, microdosing is of special interest to investigate BBB penetration, receptor binding, or dose-to-target-organ relationships. Also, first evidence on metabolism can be obtained. Microdosing represents a considerable cost and time advantage and helps to minimise attrition rates in CNS compound development.

ABX-CRO offers different PET study types

Pharmacokinetic PET studies

PET studies using radioanalogues of NCEs labelled with 11carbon allow to quantitatively assess pharmacokinetics and metabolism. In combination with behavioural, clinical or paraclinical data, pharmacokinetic PET studies allow the establishment of dose-efficacy relationships and dose finding.

Pharmacodynamic PET studies

PET studies using cold NCEs in combination with established radiotracers allow to assess pharmacodynamic properties. Using metabolic tracers such as e.g. [18F]FDG, drug effects on metabolism can be studied. Using [11C]-labelled standard ligands to a target molecule, receptor binding properties of the NCE can be assessed in vivo by displacement studies.

PET tracer development studies

For PET radiopharmaceuticals to be developed as diagnostic products in their own right, ABX-CRO performs integrated development programmes from preclinical through to registration.

Services include:

  • Strategy consultancy
  • Custom labelling (11C, 18F, 68Ga)
  • GMP-radiosynthesis
  • Radiopharmacology & dosimetry
  • Human dosimetry
  • Advanced data analysis
    • Kinetic modelling
    • Receptor occupancy
  • Full service projects
« Show less
Rodents
Non-human primates
Animal Models and Studies
Price on request
Request a quote for more information about this service.
Animal Model in vivo Analyses
Price on request
Request a quote for more information about this service.
Animal Imaging
Price on request
Request a quote for more information about this service.
Clinical Research
Price on request
Request a quote for more information about this service.
Clinical Trials, Consulting, and Management
Price on request
Request a quote for more information about this service.
Clinical Imaging Services
Price on request
Request a quote for more information about this service.
Imaging & Spectroscopy
Price on request
Request a quote for more information about this service.
Pharmacology & Toxicology
Price on request
Request a quote for more information about this service.
Computational Modeling
Price on request
Request a quote for more information about this service.
Data Services
Price on request
Request a quote for more information about this service.
Image Analysis
Price on request
Request a quote for more information about this service.
Biostatistics & Bioinformatics
Price on request
Request a quote for more information about this service.

ABX-CRO advanced pharmaceutical services GmbH has not received any ratings.

Be the first to endorse ABX-CRO advanced pharmaceutical services GmbH

Endorse this lab